Pharmaceutical Industry Information Portal

HomeTagsCOVID-19

All posts by tag

COVID-19

Russian Ministry of Health registered Mir-19 anti-coronavirus drug

The Russian Ministry of Health registered the Mir-19 coronavirus pharmaceuticals developed by the Russian Federal Medical-Biological Agency (FMBA), the agency’s press service said. The press...

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets)...

Xevudy (sotrovimab) granted marketing authorisation by the EC for the early treatment of COVID-19

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the European Commission (EC) has granted marketing authorisation to Xevudy (sotrovimab) for the early treatment of COVID-19....

Phase 3 clinical trial results of Coronavir (favipiravir) published in US Journal

The American Journal of Translational Research has published successful results of the Phase 3 clinical trial of Coronavir (INN: favipiravir). This study aimed to evaluate the efficacy and safety of favipiravir for treatment of mild...

M. Smagin: a competent system of joint planning of drugs procurements by the government and pharmaceutical business will eliminate possible shortages

In his speech at the «360 degree Pharmaceutical Supply» conference, Maxim Smagin, General Director of Promomed Group said: The domestic health care system has...

Kira Zaslavskaya: we need joint and responsible work of all participants in the pharmaceutical market

«Vision and participation are essential to address global pharmaceutical safety challenges, including the fight against the pandemic. This means that only in conditions of...
spot_img

Expert Articles

spot_img